Trial record 1 of 6 for:    Dense Deposit Disease
Previous Study | Return to List | Next Study

Clinical Trial of CDX-1135 in Pediatric and Adult Patients With Dense Deposit Disease

This study has been terminated.
(Portfolio prioritization due to slow enrollment and variable spectrum of potential complement abnormalities in DDD patients.)
Sponsor:
Information provided by (Responsible Party):
Celldex Therapeutics
ClinicalTrials.gov Identifier:
NCT01791686
First received: January 29, 2013
Last updated: March 6, 2014
Last verified: March 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: March 2014
  Primary Completion Date: March 2014 (Final data collection date for primary outcome measure)